Abbott India Q4 PAT seen up 55.7% YoY to Rs. 172.8 cr: Sharekhan

Net Sales are expected to increase by 4 percent Y-o-Y (down 8.8 percent Q-o-Q) to Rs. 999.6 crore, according to Sharekhan.

Broker Research
April 12, 2021 / 09:02 PM IST

_pharmaceuticals_190_75872574

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan has come out with its fourth quarter (January-March’ 21) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Abbott India to report net profit at Rs. 172.8 crore up 55.7% year-on-year (down 2.4% quarter-on-quarter).


Net Sales are expected to increase by 4 percent Y-o-Y (down 8.8 percent Q-o-Q) to Rs. 999.6 crore, according to Sharekhan.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More Read More

Broker Research
TAGS: #Abbott India #Brokerage Recos - Sector Report #Brokerage Results Estimates #earnings #Pharmaceuticals #Result Poll #Sharekhan
first published: Apr 12, 2021 09:02 pm